In line with this in silico data, a proteomic analysis of lung-tumor samples has identified TENM2 expression as a marker with which to better classify neoplastic lesions in the lung, as it is highly and homogenously expressed in pleural mesothelioma compared to lung adenocarcinoma cell lines [68]. The gene discussed is TENM2; the disease is neoplasm.